Literature DB >> 11350924

26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.

P Cascio1, C Hilton, A F Kisselev, K L Rock, A L Goldberg.   

Abstract

Protein degradation by proteasomes is the source of most antigenic peptides presented on MHC class I molecules. To determine whether proteasomes generate these peptides directly or longer precursors, we developed new methods to measure the efficiency with which 26S and 20S particles, during degradation of a protein, generate the presented epitope or potential precursors. Breakdown of ovalbumin by the 26S and 20S proteasomes yielded the immunodominant peptide SIINFEKL, but produced primarily variants containing 1-7 additional N-terminal residues. Only 6-8% of the times that ovalbumin molecules were digested was a SIINFEKL or an N-extended version produced. Surprisingly, immunoproteasomes which contain the interferon-gamma-induced beta-subunits and are more efficient in antigen presentation, produced no more SIINFEKL than proteasomes. However, the immunoproteasomes released 2-4 times more of certain N-extended versions. These observations show that the changes in cleavage specificity of immunoproteasomes influence not only the C-terminus, but also the N-terminus of potential antigenic peptides, and suggest that most MHC-presented peptides result from N-terminal trimming of larger proteasome products by aminopeptidases (e.g. the interferon-gamma-induced enzyme leucine aminopeptidase).

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2001        PMID: 11350924      PMCID: PMC125470          DOI: 10.1093/emboj/20.10.2357

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER.

Authors:  P Paz; N Brouwenstijn; R Perry; N Shastri
Journal:  Immunity       Date:  1999-08       Impact factor: 31.745

2.  Sequences that flank subdominant and cryptic epitopes influence the proteolytic generation of MHC class I-presented peptides.

Authors:  A X Mo; S F van Lelyveld; A Craiu; K L Rock
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

Review 3.  A proteasome howdunit: the case of the missing signal.

Authors:  R Verma; R J Deshaies
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

4.  Rapid degradation of a large fraction of newly synthesized proteins by proteasomes.

Authors:  U Schubert; L C Antón; J Gibbs; C C Norbury; J W Yewdell; J R Bennink
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

Review 5.  The specificity of proteasomes: impact on MHC class I processing and presentation of antigens.

Authors:  G Niedermann; E Geier; M Lucchiari-Hartz; N Hitziger; A Ramsperger; K Eichmann
Journal:  Immunol Rev       Date:  1999-12       Impact factor: 12.988

6.  Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.

Authors:  K Schwarz; M van Den Broek; S Kostka; R Kraft; A Soza; G Schmidtke; P M Kloetzel; M Groettrup
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

7.  The major substrates for TAP in vivo are derived from newly synthesized proteins.

Authors:  E A Reits; J C Vos; M Grommé; J Neefjes
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

8.  Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.

Authors:  M Lucchiari-Hartz; P M van Endert; G Lauvau; R Maier; A Meyerhans; D Mann; K Eichmann; G Niedermann
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

9.  Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes.

Authors:  A J Sijts; T Ruppert; B Rehermann; M Schmidt; U Koszinowski; P M Kloetzel
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

10.  Human transporters associated with antigen processing (TAPs) select epitope precursor peptides for processing in the endoplasmic reticulum and presentation to T cells.

Authors:  G Lauvau; K Kakimi; G Niedermann; M Ostankovitch; P Yotnda; H Firat; F V Chisari; P M van Endert
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

View more
  95 in total

1.  PI31 is a modulator of proteasome formation and antigen processing.

Authors:  Dietmar M W Zaiss; Sybille Standera; Peter-M Kloetzel; Alice J A M Sijts
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

2.  Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome.

Authors:  Can Kesmir; Vera van Noort; Rob J de Boer; Paulien Hogeweg
Journal:  Immunogenetics       Date:  2003-08-30       Impact factor: 2.846

Review 3.  Towards a systems understanding of MHC class I and MHC class II antigen presentation.

Authors:  Jacques Neefjes; Marlieke L M Jongsma; Petra Paul; Oddmund Bakke
Journal:  Nat Rev Immunol       Date:  2011-11-11       Impact factor: 53.106

4.  Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules.

Authors:  Danielle de Verteuil; Tara L Muratore-Schroeder; Diana P Granados; Marie-Hélène Fortier; Marie-Pierre Hardy; Alexandre Bramoullé; Etienne Caron; Krystel Vincent; Sylvie Mader; Sébastien Lemieux; Pierre Thibault; Claude Perreault
Journal:  Mol Cell Proteomics       Date:  2010-05-19       Impact factor: 5.911

5.  Identification of potential HLA class I and class II epitope precursors associated with heat shock protein 70 (HSPA).

Authors:  Pawel Stocki; Nicholas J Morris; Christian Preisinger; Xiao N Wang; Walter Kolch; Gabriele Multhoff; Anne M Dickinson
Journal:  Cell Stress Chaperones       Date:  2010-04-01       Impact factor: 3.667

6.  Nature of pharmacophore influences active site specificity of proteasome inhibitors.

Authors:  Michael Screen; Matthew Britton; Sondra L Downey; Martijn Verdoes; Mathias J Voges; Annet E M Blom; Paul P Geurink; Martijn D P Risseeuw; Bogdan I Florea; Wouter A van der Linden; Alexandre A Pletnev; Herman S Overkleeft; Alexei F Kisselev
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

7.  Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells.

Authors:  Nicolas Blanchard; Takayuki Kanaseki; Hernando Escobar; Frédéric Delebecque; Niranjana A Nagarajan; Eduardo Reyes-Vargas; David K Crockett; David H Raulet; Julio C Delgado; Nilabh Shastri
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

8.  Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1.

Authors:  W M Cohen; A Bianco; F Connan; L Camoin; M Dalod; G Lauvau; E Ferriès; B Culmann-Penciolelli; P M van Endert; J P Briand; J Choppin; J G Guillet
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 9.  Hepatitis C virus and ethanol alter antigen presentation in liver cells.

Authors:  Natalia A Osna
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

10.  Competition for antigen at the level of the APC is a major determinant of immunodominance during memory inflation in murine cytomegalovirus infection.

Authors:  Lila A Farrington; Tameka A Smith; Finn Grey; Ann B Hill; Christopher M Snyder
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.